LINC00998 Modulating M2 Macrophage Activation in Allergic Rhinitis by Stabilizing BOB.1 mRNA

References

• Brozek JL, Bousquet J, Agache I, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. doi:10.1016/j.jaci.2017.03.050
   PubMed Web of Science ®Google Scholar
• Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nat Rev Dis Primers. 2020;6(1):95. doi:10.1038/s41572-020-00227-0
   PubMed Web of Science ®Google Scholar
• Tomazic PV, Lang-Loidolt D. Current and emerging pharmacotherapy for pediatric allergic rhinitis. Expert Opin Pharmacother. 2021;22(7):849–855. doi:10.1080/14656566.2020.1808622
   PubMed Web of Science ®Google Scholar
• Di Lorenzo G, Di Bona D, Belluzzo F, et al. Immunological and non-immunological mechanisms of allergic diseases in the elderly: biological and clinical characteristics. Immun Ageing. 2017;14:23. doi:10.1186/s12979-017-0105-4
   PubMed Web of Science ®Google Scholar
• Wang A, Singh K, Ibrahim W, et al. The promise of JAK inhibitors for treatment of sarcoidosis and other inflammatory disorders with macrophage activation: a review of the literature. Yale J Biol Med. 2020;93(1):187–195.
   PubMed Web of Science ®Google Scholar
• Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–6440. doi:10.1002/jcp.26429
   PubMed Web of Science ®Google Scholar
• Ivashkiv LB. Epigenetic regulation of macrophage polarization and function. Trends Immunol. 2013;34(5):216–223. doi:10.1016/j.it.2012.11.001
   PubMed Web of Science ®Google Scholar
• Saradna A, Do DC, Kumar S, et al. Macrophage polarization and allergic asthma. Transl Res. 2018;191:1–14. doi:10.1016/j.trsl.2017.09.002
   PubMed Web of Science ®Google Scholar
• Ogulur I, Pat Y, Ardicli O, et al. Advances and highlights in biomarkers of allergic diseases. Allergy. 2021;76(12):3659–3686. doi:10.1111/all.15089
   PubMed Web of Science ®Google Scholar
• Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med. 2018;22(12):5768–5775. doi:10.1111/jcmm.13866
   PubMed Web of Science ®Google Scholar
• Guidi R, Wedeles CJ, Wilson MS. ncRNAs in Type-2 Immunity. Noncoding RNA. 2020;6(1):10. doi:10.3390/ncrna6010010
   PubMed Web of Science ®Google Scholar
• Xu F, Jin L, Jin Y, et al. Long noncoding RNAs in autoimmune diseases. J Biomed Mater Res A. 2019;107(2):468–475. doi:10.1002/jbm.a.36562
   PubMed Web of Science ®Google Scholar
• Ribatti D. The discovery of immunoglobulin E. Immunol Lett. 2016;171:1–4. doi:10.1016/j.imlet.2016.01.001
   PubMed Web of Science ®Google Scholar
• Xiao Y, Pan J, Geng Q, et al. Retracted: lnc RNA MALAT 1 increases the stemness of gastric cancer cells via enhancing SOX 2 mRNA stability. FEBS Open Bio. 2019;9(7):1212–1222. doi:10.1002/2211-5463.12649
   PubMed Web of Science ®Google Scholar
• Wu H, He Y, Chen H, et al. Retracted: lnc RNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX 9 mRNA stability. FEBS Open Bio. 2019;9(4):781–790. doi:10.1002/2211-5463.12620
   PubMed Web of Science ®Google Scholar
• Mao C, Li X. Long noncoding RNA OIP5-AS1 promotes the stemness of lung cancer cells through enhancing Oct4 mRNA stability. Environ Toxicol: Int J. 2022;37(5):1104–1112. doi:10.1002/tox.23468
   PubMed Web of Science ®Google Scholar
• Yeremenko N, Danger R, Baeten D, et al. Transcriptional regulator BOB.1: molecular mechanisms and emerging role in chronic inflammation and autoimmunity. Autoimmun Rev. 2021;20(6):102833. doi:10.1016/j.autrev.2021.102833
   PubMed Web of Science ®Google Scholar
• Brunner C, Sindrilaru A, Girkontaite I, et al. BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses. EMBO J. 2007;26(13):3191–3202. doi:10.1038/sj.emboj.7601742
   PubMed Web of Science ®Google Scholar
• Kelly BT, Grayson MH. Immunoglobulin E, what is it good for? Ann Allergy Asthma Immunol. 2016;116(3):183–187. doi:10.1016/j.anai.2015.10.026
   PubMed Web of Science ®Google Scholar
• Waldmann TA, Sherwood LM, Parris EE. Disorders of immunoglobulin metabolism. N Engl J Med. 1969;281(21):1170–1177. doi:10.1056/NEJM196911202812107
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lan F, Zhang L. Update on pathomechanisms and treatments in allergic rhinitis. Allergy. 2022;77(11):3309–3319. doi:10.1111/all.15454
   PubMed Web of Science ®Google Scholar
• Poddighe D, Mathias CB, Brambilla I, Marseglia GL, Oettgen HC. Importance of basophils in eosinophilic asthma: the murine counterpart. J Biol Regul Homeost Agents. 2018;32(2):335–339.
   PubMed Web of Science ®Google Scholar
• van Rijt L, von Richthofen H, van Ree R. Type 2 innate lymphoid cells: at the cross-roads in allergic asthma. Semin Immunopathol. 2016;38(4):483–496. doi:10.1007/s00281-016-0556-2
   PubMed Web of Science ®Google Scholar
• Chupp GL, Lee CG, Jarjour N, et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med. 2007;357(20):2016–2027. doi:10.1056/NEJMoa073600
   PubMed Web of Science ®Google Scholar
• Ford AQ, Dasgupta P, Mikhailenko I, et al. Adoptive transfer of IL-4Ralpha+ macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation. BMC Immunol. 2012;13:6. doi:10.1186/1471-2172-13-6
   PubMed Web of Science ®Google Scholar
• Draijer C, Robbe P, Boorsma CE, et al. Characterization of macrophage phenotypes in three murine models of house-dust-mite-induced asthma. Mediators Inflamm. 2013;2013:632049. doi:10.1155/2013/632049
   PubMed Web of Science ®Google Scholar
• Melgert BN, ten Hacken NH, Rutgers B, et al. More alternative activation of macrophages in lungs of asthmatic patients. J Allergy Clin Immunol. 2011;127(3):831–833. doi:10.1016/j.jaci.2010.10.045
   PubMed Web of Science ®Google Scholar
• Funes SC, Rios M, Escobar‐Vera J, et al. Implications of macrophage polarization in autoimmunity. Immunology. 2018;154(2):186–195. doi:10.1111/imm.12910
   PubMed Web of Science ®Google Scholar
• Akinrinmade OA, Chetty S, Daramola AK, et al. CD64: an attractive immunotherapeutic target for M1-type macrophage mediated chronic inflammatory diseases. Biomedicines. 2017;5(3):56. doi:10.3390/biomedicines5030056
   PubMed Web of Science ®Google Scholar
• Ma SF, Chen Y-J, Zhang J-X, et al. Adoptive transfer of M2 macrophages promotes locomotor recovery in adult rats after spinal cord injury. Brain Behav Immun. 2015;45:157–170. doi:10.1016/j.bbi.2014.11.007
   PubMed Web of Science ®Google Scholar
• Harusato A, Naito Y, Takagi T, et al. BTB and CNC homolog 1 (Bach1) deficiency ameliorates TNBS colitis in mice: role of M2 macrophages and heme oxygenase-1. Inflamm Bowel Dis. 2013;19(4):740–753. doi:10.1097/MIB.0b013e3182802968
   PubMed Web of Science ®Google Scholar
• Xia L, Wang X, Liu L, et al. lnc-BAZ2B promotes M2 macrophage activation and inflammation in children with asthma through stabilizing BAZ2B pre-mRNA. J Allergy Clin Immunol. 2021;147(3):921–932.e9. doi:10.1016/j.jaci.2020.06.034
   PubMed Web of Science ®Google Scholar
• Han X, Huang S, Xue P, et al. LncRNA PTPRE-AS1 modulates M2 macrophage activation and inflammatory diseases by epigenetic promotion of PTPRE. Sci Adv. 2019;5(12):x9230. doi:10.1126/sciadv.aax9230
   Web of Science ®Google Scholar
• Self-Fordham JB. MicroRNA: dynamic regulators of macrophage polarization and plasticity. Front Immunol. 2017;8:1062.
   PubMed Web of Science ®Google Scholar
• Nagarkar DR, Bowman ER, Schneider D, et al. Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages. J Immunol. 2010;185(4):2525–2535. doi:10.4049/jimmunol.1000286
   PubMed Web of Science ®Google Scholar
• Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15(1):7–21. doi:10.1038/nrg3606
   PubMed Web of Science ®Google Scholar
• Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904–914.
   PubMed Web of Science ®Google Scholar
• Maurano MT, Humbert R, Rynes E, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science. 2012;337(6099):1190–1195. doi:10.1126/science.1222794
   PubMed Web of Science ®Google Scholar
• Nakamura M, Nishida N, Kawashima M, et al. Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet. 2012;91(4):721–728. doi:10.1016/j.ajhg.2012.08.010
   PubMed Web of Science ®Google Scholar
• Ban M. Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans. J Neuroimmunol. 2006;179(1–2):108–116. doi:10.1016/j.jneuroim.2006.06.003
   PubMed Web of Science ®Google Scholar
• Shakerian L, Ghorbani S, Talebi F, et al. MicroRNA-150 targets PU.1 and regulates macrophage differentiation and function in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2018;323:167–174. doi:10.1016/j.jneuroim.2018.06.010
   PubMed Web of Science ®Google Scholar
• Ueno N, Nishimura N, Ueno S, et al. PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4. Oncogene. 2017;36(31):4481–4497.
   PubMed Web of Science ®Google Scholar
• Marecki S, Riendeau CJ, Liang MD, et al. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene. J Immunol. 2001;166(11):6829–6838. doi:10.4049/jimmunol.166.11.6829
   PubMed Web of Science ®Google Scholar
• Ha SD, Cho W, DeKoter RP, et al. The transcription factor PU.1 mediates enhancer-promoter looping that is required for IL-1beta eRNA and mRNA transcription in mouse melanoma and macrophage cell lines. J Biol Chem. 2019;294(46):17487–17500. doi:10.1074/jbc.RA119.010149
   PubMed Web of Science ®Google Scholar
• Yang C, Shangguan C, Cai C, et al. LncRNA HCP5 participates in the tregs functions in allergic rhinitis and drives airway mucosal inflammatory response in the nasal epithelial cells. Inflammation. 2022;45(3):1281–1297. doi:10.1007/s10753-022-01620-5
   PubMed Web of Science ®Google Scholar
• Ma Z, Lian H, Lin X, et al. LncRNA MIAT promotes allergic inflammation and symptoms by targeting MiR-10b-5p in allergic rhinitis mice. Am J Rhinol Allergy. 2021;35(6):781–789. doi:10.1177/1945892421998143
   PubMed Web of Science ®Google Scholar
• Wu X, Zhao S, Huang W, et al. Aberrant expressions of circulating lncRNA NEAT1 and microRNA-125a are linked with Th2 cells and symptom severity in pediatric allergic rhinitis. J Clin Lab Anal. 2022;36(3):e24235. doi:10.1002/jcla.24235
   PubMed Web of Science ®Google Scholar
• Wu XH, Zhao SJ, Huang WQ, et al. Long non-coding RNA MALAT1 promotes Th2 differentiation by regulating microRNA-135b-5p/GATA-3 axis in children with allergic rhinitis. Kaohsiung J Med Sci. 2022;38(10):971–980.
   PubMed Web of Science ®Google Scholar
• Song J, Liu D, Yin W. lnc-THRIL and miR-125b relate to disease risk, severity, and imbalance of Th1 cells/Th2 cells in allergic rhinitis. Allergol Immunopathol. 2022;50(3):15–23. doi:10.15586/aei.v50i3.528
   PubMed Web of Science ®Google Scholar
• Yue L, Yin X, Hao F, et al. Long noncoding RNA linc00632 inhibits interleukin-13-induced inflammatory cytokine and mucus production in nasal epithelial cells. J Innate Immun. 2020;12(1):116–128. doi:10.1159/000500420
   PubMed Web of Science ®Google Scholar
• Li L, Deng J, Huang T, et al. IRF4 transcriptionally activate HOTAIRM1, which in turn regulates IRF4 expression, thereby affecting Th9 cell differentiation and involved in allergic rhinitis. Gene. 2022;813:146118. doi:10.1016/j.gene.2021.146118
   PubMed Web of Science ®Google Scholar